Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,223 | -3,588 | -5,825 | -5,814 | N/A |
| Depreciation Amortization | 6 | 5 | 8 | 5 | N/A |
| Other Working Capital | -596 | 521 | 352 | 573 | N/A |
| Other Operating Activity | 81 | -3,063 | -2,434 | -330 | 0 |
| Operating Cash Flow | $-6,732 | $-6,124 | $-7,899 | $-5,565 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,277 | N/A | N/A | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | -4 | N/A |
| Other Investing Activity | 0 | -270 | -109 | 464 | 0 |
| Investing Cash Flow | $-11,277 | $-270 | $-109 | $460 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 30,634 | 2,728 | 366 | 7,032 | N/A |
| Other Financing Activity | 2,658 | 2,471 | 0 | 4,689 | 0 |
| Financing Cash Flow | $33,293 | $5,198 | $366 | $11,721 | $N/A |
| Exchange Rate Effect | -2 | 24 | -238 | 12 | N/A |
| Beginning Cash Position | 1,783 | 3,001 | 10,953 | 4,067 | N/A |
| End Cash Position | 17,064 | 1,807 | 3,073 | 10,694 | N/A |
| Net Cash Flow | $15,282 | $-1,195 | $-7,880 | $6,627 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,732 | -6,124 | -7,899 | -5,565 | N/A |
| Capital Expenditure | N/A | N/A | N/A | -4 | N/A |
| Free Cash Flow | -6,732 | -6,124 | -7,899 | -5,569 | 0 |